<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03715803</url>
  </required_header>
  <id_info>
    <org_study_id>CaSCaA</org_study_id>
    <nct_id>NCT03715803</nct_id>
  </id_info>
  <brief_title>Calistar A vs. Calistar S - Comparative Cohort Retrospective Analysis of Single Incision POP Systems</brief_title>
  <official_title>Calistar A vs. Calistar S - Cohort Retrospective Analysis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Agustin Sampietro</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Buenos Aires</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main objective of this study is to compare the initial outcomes and complication of two
      meshes implanted through a single incision to treat anterior and apical prolapses, Calistar A
      and a second-generation low weight mesh called Calistar S (Soft).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The main objective of this study is to compare the initial outcomes and complication of two
      meshes implanted through a single incision to treat anterior and apical prolapses, Calistar A
      and a second-generation low weight mesh called Calistar S (Soft). In such sense, objective
      and subjective parameters will be retrospectively tested to demonstrate the safety and
      effectiveness of this products. Safety will be assessed by register of complications and
      effectiveness will be evaluated by pelvic floor reconstruction and quality of life
      improvements.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 25, 2018</start_date>
  <completion_date type="Actual">December 30, 2019</completion_date>
  <primary_completion_date type="Actual">August 20, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of Cured Participants According to Barber Criteria</measure>
    <time_frame>Post-operative at 6 months</time_frame>
    <description>According to Barber criteria cure is defined if there are no points beyond the hymen (measure by POP-Q quantification), an absence of vaginal bulge symptoms and no re-treatment/interventions on year post procedure.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants Cured According to Objective Measure (POP-Q Quantification)</measure>
    <time_frame>Pre-operative and post-operative at 6 months</time_frame>
    <description>Assessment of POP with POP-Q quantification. Number of participants cured according to POP-Q quantification. Success criteria: POP-Q stage equal 0 or 1.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life Status: Patient Global Impression Questionnaire</measure>
    <time_frame>Post-operative at 6 months</time_frame>
    <description>Patient satisfaction with the experience and the result of procedure will be evaluated with the &quot;Patient Global Impression&quot; questionnaire. This is a visual analogue scale range 1 (very much worse) - 5 (very much improved). A higher score a better outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse Events</measure>
    <time_frame>Intra-operative and post-operative at 6 months</time_frame>
    <description>Register of adverse events. Clavien-Dindo classification</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Quality of Life: PFDI 20</measure>
    <time_frame>Post-operative at 6 months</time_frame>
    <description>Quality of life assessed with &quot;Pelvic Floor Distress Inventory (PFDI 20)&quot; questionnaire to evaluate the impact of urinary, prolapse and colorectal distress post-operative. The sum of the scores of these 3 scales serves as the overall summary score of the PFDI-20 and ranges from 0 (least distress) to 100 (greatest distress).</description>
  </other_outcome>
  <other_outcome>
    <measure>Quality of Life: PISQ-12</measure>
    <time_frame>Post-operative at 6 months</time_frame>
    <description>Quality of life assessed with &quot;Pelvic Organ Prolapse/ Urinary Incontinence Sexual Questionnaire (PISQ-12)&quot; to evaluate sexual function in women with pelvic organ prolapse and/or urinary incontinence post-operative. Higher PISQ-12 scores indicate a better sexual function. Maximum score is 48.</description>
  </other_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">217</enrollment>
  <condition>Pelvic Organ Prolapse</condition>
  <arm_group>
    <arm_group_label>Calistar A</arm_group_label>
    <description>Calistar A mesh to treat anterior and apical POP</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Calistar S</arm_group_label>
    <description>Calistar S mesh to treat anterior and apical POP</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Calistar A mesh to treat anterior and apical POP</intervention_name>
    <description>Single incision surgery using Calistar A mesh to treat anterior and apical pelvic prolapses</description>
    <arm_group_label>Calistar A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Calistar S mesh to treat anterior and apical POP</intervention_name>
    <description>Single incision surgery using Calistar S to treat anterior and apical pelvic prolapses</description>
    <arm_group_label>Calistar S</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adults female
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Female

          -  Anterior and apical prolapse Stage 3 (according to POP-Q) or more with or without
             stress urinary incontinence (SUI)

          -  Primary or recurrent treatment with Calistar S or Calistar A

          -  At least 6 months follow-up

        Exclusion Criteria:

          -  Recurrent vaginal infections,

          -  Chronic colorectal diseases (chronic nonspecific ulcerative colitis, diverticulitis,
             diverticulosis, Chron's disease, irritable bowel syndrome, familial polyposis).

          -  Presence of any coagulopathies,

          -  Impairment of the immune system or any condition that compromises recovery,

          -  Prior irradiation

          -  Chronic pelvic pain
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Agustín Sampietro, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Faculty of Medicine, University of Buenos Aires</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital Británico</name>
      <address>
        <city>Buenos Aires</city>
        <zip>C1280AEB</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Argentina</country>
  </location_countries>
  <reference>
    <citation>de Tayrac R, Madelenat P. [Evolution of surgical routes in female stress urinary incontinence]. Gynecol Obstet Fertil. 2004 Dec;32(12):1031-8. Review. French.</citation>
    <PMID>15589779</PMID>
  </reference>
  <reference>
    <citation>Bigozzi MA, Provenzano S, Maeda F, Palma P, Riccetto C. In vivo biomechanical properties of heavy versus light weight monofilament polypropylene meshes. Does the knitting pattern matter? Neurourol Urodyn. 2017 Jan;36(1):73-79. doi: 10.1002/nau.22890. Epub 2015 Oct 5.</citation>
    <PMID>26436858</PMID>
  </reference>
  <reference>
    <citation>Barber MD, Brubaker L, Nygaard I, Wheeler TL 2nd, Schaffer J, Chen Z, Spino C; Pelvic Floor Disorders Network. Defining success after surgery for pelvic organ prolapse. Obstet Gynecol. 2009 Sep;114(3):600-9. doi: 10.1097/AOG.0b013e3181b2b1ae.</citation>
    <PMID>19701041</PMID>
  </reference>
  <reference>
    <citation>Toozs-Hobson P, Freeman R, Barber M, Maher C, Haylen B, Athanasiou S, Swift S, Whitmore K, Ghoniem G, de Ridder D; International Urogynecological Association; International Continence Society. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for reporting outcomes of surgical procedures for pelvic organ prolapse. Neurourol Urodyn. 2012 Apr;31(4):415-21. doi: 10.1002/nau.22238.</citation>
    <PMID>22517068</PMID>
  </reference>
  <reference>
    <citation>Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, de Santibañes E, Pekolj J, Slankamenac K, Bassi C, Graf R, Vonlanthen R, Padbury R, Cameron JL, Makuuchi M. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009 Aug;250(2):187-96. doi: 10.1097/SLA.0b013e3181b13ca2.</citation>
    <PMID>19638912</PMID>
  </reference>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>September 26, 2018</study_first_submitted>
  <study_first_submitted_qc>October 19, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 23, 2018</study_first_posted>
  <results_first_submitted>January 31, 2020</results_first_submitted>
  <results_first_submitted_qc>March 6, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">March 20, 2020</results_first_posted>
  <last_update_submitted>March 6, 2020</last_update_submitted>
  <last_update_submitted_qc>March 6, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 20, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Buenos Aires</investigator_affiliation>
    <investigator_full_name>Agustin Sampietro</investigator_full_name>
    <investigator_title>Gynecologist</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prolapse</mesh_term>
    <mesh_term>Pelvic Organ Prolapse</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Only final clinical study report will be shared with the researchers participating in the study</ipd_description>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>May 28, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/03/NCT03715803/Prot_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>May 28, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/03/NCT03715803/SAP_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Calistar A</title>
          <description>Calistar A mesh to treat anterior and apical POP
Calistar A mesh to treat anterior and apical POP: Single incision surgery using Calistar A mesh to treat anterior and apical pelvic prolapses</description>
        </group>
        <group group_id="P2">
          <title>Calistar S</title>
          <description>Calistar S mesh to treat anterior and apical POP
Calistar S mesh to treat anterior and apical POP: Single incision surgery using Calistar S to treat anterior and apical pelvic prolapses</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="91"/>
                <participants group_id="P2" count="126"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="91"/>
                <participants group_id="P2" count="126"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Calistar A</title>
          <description>Calistar A mesh to treat anterior and apical POP
Calistar A mesh to treat anterior and apical POP: Single incision surgery using Calistar A mesh to treat anterior and apical pelvic prolapses</description>
        </group>
        <group group_id="B2">
          <title>Calistar S</title>
          <description>Calistar S mesh to treat anterior and apical POP
Calistar S mesh to treat anterior and apical POP: Single incision surgery using Calistar S to treat anterior and apical pelvic prolapses</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="91"/>
            <count group_id="B2" value="126"/>
            <count group_id="B3" value="217"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="91"/>
                    <count group_id="B2" value="126"/>
                    <count group_id="B3" value="217"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="62" spread="9"/>
                    <measurement group_id="B2" value="62" spread="8"/>
                    <measurement group_id="B3" value="62" spread="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="91"/>
                    <count group_id="B2" value="126"/>
                    <count group_id="B3" value="217"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="91"/>
                    <measurement group_id="B2" value="126"/>
                    <measurement group_id="B3" value="217"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Argentina</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="91"/>
                    <count group_id="B2" value="126"/>
                    <count group_id="B3" value="217"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="32"/>
                    <measurement group_id="B2" value="71"/>
                    <measurement group_id="B3" value="103"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Brazil</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="91"/>
                    <count group_id="B2" value="126"/>
                    <count group_id="B3" value="217"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="23"/>
                    <measurement group_id="B2" value="19"/>
                    <measurement group_id="B3" value="42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Italy</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="91"/>
                    <count group_id="B2" value="126"/>
                    <count group_id="B3" value="217"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="29"/>
                    <measurement group_id="B2" value="30"/>
                    <measurement group_id="B3" value="59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>France</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="91"/>
                    <count group_id="B2" value="126"/>
                    <count group_id="B3" value="217"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Percentage of Cured Participants According to Barber Criteria</title>
        <description>According to Barber criteria cure is defined if there are no points beyond the hymen (measure by POP-Q quantification), an absence of vaginal bulge symptoms and no re-treatment/interventions on year post procedure.</description>
        <time_frame>Post-operative at 6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Calistar A</title>
            <description>Calistar A mesh to treat anterior and apical POP
Calistar A mesh to treat anterior and apical POP: Single incision surgery using Calistar A mesh to treat anterior and apical pelvic prolapses</description>
          </group>
          <group group_id="O2">
            <title>Calistar S</title>
            <description>Calistar S mesh to treat anterior and apical POP
Calistar S mesh to treat anterior and apical POP: Single incision surgery using Calistar S to treat anterior and apical pelvic prolapses</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Cured Participants According to Barber Criteria</title>
          <description>According to Barber criteria cure is defined if there are no points beyond the hymen (measure by POP-Q quantification), an absence of vaginal bulge symptoms and no re-treatment/interventions on year post procedure.</description>
          <units>percentage of cured patients</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="91"/>
                <count group_id="O2" value="126"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="82.42"/>
                    <measurement group_id="O2" value="90.48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Participants Cured According to Objective Measure (POP-Q Quantification)</title>
        <description>Assessment of POP with POP-Q quantification. Number of participants cured according to POP-Q quantification. Success criteria: POP-Q stage equal 0 or 1.</description>
        <time_frame>Pre-operative and post-operative at 6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Calistar A</title>
            <description>Calistar A mesh to treat anterior and apical POP
Calistar A mesh to treat anterior and apical POP: Single incision surgery using Calistar A mesh to treat anterior and apical pelvic prolapses</description>
          </group>
          <group group_id="O2">
            <title>Calistar S</title>
            <description>Calistar S mesh to treat anterior and apical POP
Calistar S mesh to treat anterior and apical POP: Single incision surgery using Calistar S to treat anterior and apical pelvic prolapses</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants Cured According to Objective Measure (POP-Q Quantification)</title>
          <description>Assessment of POP with POP-Q quantification. Number of participants cured according to POP-Q quantification. Success criteria: POP-Q stage equal 0 or 1.</description>
          <units>percentage of cured patients</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="91"/>
                <count group_id="O2" value="126"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="82.42"/>
                    <measurement group_id="O2" value="88.88"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Quality of Life Status: Patient Global Impression Questionnaire</title>
        <description>Patient satisfaction with the experience and the result of procedure will be evaluated with the &quot;Patient Global Impression&quot; questionnaire. This is a visual analogue scale range 1 (very much worse) - 5 (very much improved). A higher score a better outcome.</description>
        <time_frame>Post-operative at 6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Calistar A</title>
            <description>Calistar A mesh to treat anterior and apical POP
Calistar A mesh to treat anterior and apical POP: Single incision surgery using Calistar A mesh to treat anterior and apical pelvic prolapses</description>
          </group>
          <group group_id="O2">
            <title>Calistar S</title>
            <description>Calistar S mesh to treat anterior and apical POP
Calistar S mesh to treat anterior and apical POP: Single incision surgery using Calistar S to treat anterior and apical pelvic prolapses</description>
          </group>
        </group_list>
        <measure>
          <title>Quality of Life Status: Patient Global Impression Questionnaire</title>
          <description>Patient satisfaction with the experience and the result of procedure will be evaluated with the &quot;Patient Global Impression&quot; questionnaire. This is a visual analogue scale range 1 (very much worse) - 5 (very much improved). A higher score a better outcome.</description>
          <units>units on a scale</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="91"/>
                <count group_id="O2" value="126"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5" lower_limit="1" upper_limit="5"/>
                    <measurement group_id="O2" value="5" lower_limit="3" upper_limit="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Adverse Events</title>
        <description>Register of adverse events. Clavien-Dindo classification</description>
        <time_frame>Intra-operative and post-operative at 6 months</time_frame>
        <population>Adverse events were presented in a separate section.</population>
        <group_list>
          <group group_id="O1">
            <title>Calistar A</title>
            <description>Calistar A mesh to treat anterior and apical POP
Calistar A mesh to treat anterior and apical POP: Single incision surgery using Calistar A mesh to treat anterior and apical pelvic prolapses</description>
          </group>
          <group group_id="O2">
            <title>Calistar S</title>
            <description>Calistar S mesh to treat anterior and apical POP
Calistar S mesh to treat anterior and apical POP: Single incision surgery using Calistar S to treat anterior and apical pelvic prolapses</description>
          </group>
        </group_list>
        <measure>
          <title>Adverse Events</title>
          <description>Register of adverse events. Clavien-Dindo classification</description>
          <population>Adverse events were presented in a separate section.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Quality of Life: PFDI 20</title>
        <description>Quality of life assessed with &quot;Pelvic Floor Distress Inventory (PFDI 20)&quot; questionnaire to evaluate the impact of urinary, prolapse and colorectal distress post-operative. The sum of the scores of these 3 scales serves as the overall summary score of the PFDI-20 and ranges from 0 (least distress) to 100 (greatest distress).</description>
        <time_frame>Post-operative at 6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Calistar A</title>
            <description>Calistar A mesh to treat anterior and apical POP
Calistar A mesh to treat anterior and apical POP: Single incision surgery using Calistar A mesh to treat anterior and apical pelvic prolapses</description>
          </group>
          <group group_id="O2">
            <title>Calistar S</title>
            <description>Calistar S mesh to treat anterior and apical POP
Calistar S mesh to treat anterior and apical POP: Single incision surgery using Calistar S to treat anterior and apical pelvic prolapses</description>
          </group>
        </group_list>
        <measure>
          <title>Quality of Life: PFDI 20</title>
          <description>Quality of life assessed with &quot;Pelvic Floor Distress Inventory (PFDI 20)&quot; questionnaire to evaluate the impact of urinary, prolapse and colorectal distress post-operative. The sum of the scores of these 3 scales serves as the overall summary score of the PFDI-20 and ranges from 0 (least distress) to 100 (greatest distress).</description>
          <units>score on a scale</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="91"/>
                <count group_id="O2" value="126"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="30.85" lower_limit="0" upper_limit="91.1"/>
                    <measurement group_id="O2" value="19.4" lower_limit="0" upper_limit="52.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Quality of Life: PISQ-12</title>
        <description>Quality of life assessed with &quot;Pelvic Organ Prolapse/ Urinary Incontinence Sexual Questionnaire (PISQ-12)&quot; to evaluate sexual function in women with pelvic organ prolapse and/or urinary incontinence post-operative. Higher PISQ-12 scores indicate a better sexual function. Maximum score is 48.</description>
        <time_frame>Post-operative at 6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Calistar A</title>
            <description>Calistar A mesh to treat anterior and apical POP
Calistar A mesh to treat anterior and apical POP: Single incision surgery using Calistar A mesh to treat anterior and apical pelvic prolapses</description>
          </group>
          <group group_id="O2">
            <title>Calistar S</title>
            <description>Calistar S mesh to treat anterior and apical POP
Calistar S mesh to treat anterior and apical POP: Single incision surgery using Calistar S to treat anterior and apical pelvic prolapses</description>
          </group>
        </group_list>
        <measure>
          <title>Quality of Life: PISQ-12</title>
          <description>Quality of life assessed with &quot;Pelvic Organ Prolapse/ Urinary Incontinence Sexual Questionnaire (PISQ-12)&quot; to evaluate sexual function in women with pelvic organ prolapse and/or urinary incontinence post-operative. Higher PISQ-12 scores indicate a better sexual function. Maximum score is 48.</description>
          <units>score on a scale</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="91"/>
                <count group_id="O2" value="126"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="5"/>
                    <measurement group_id="O2" value="0" lower_limit="0" upper_limit="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>All adverse events were collected within a FU of 24 mo (6-64 mo) for Ca A and 12 mo (6-36 mo) for Ca S</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Calistar A</title>
          <description>Calistar A mesh to treat anterior and apical POP
Calistar A mesh to treat anterior and apical POP: Single incision surgery using Calistar A mesh to treat anterior and apical pelvic prolapses</description>
        </group>
        <group group_id="E2">
          <title>Calistar S</title>
          <description>Calistar S mesh to treat anterior and apical POP
Calistar S mesh to treat anterior and apical POP: Single incision surgery using Calistar S to treat anterior and apical pelvic prolapses</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="91"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="126"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="91"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="126"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="30" subjects_at_risk="91"/>
                <counts group_id="E2" subjects_affected="14" subjects_at_risk="126"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" events="12" subjects_affected="12" subjects_at_risk="91"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="126"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Pain</sub_title>
                <assessment>Systematic Assessment</assessment>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="91"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="126"/>
              </event>
              <event>
                <sub_title>Reoperation for prolapse</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="91"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="126"/>
              </event>
              <event>
                <sub_title>Mesh erosion</sub_title>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="91"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="126"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Retrospective study; CaA procedures started a long time before the first CaS cases (Ca S level of surgeon training more experienced). Available data only enables mid-term follow-ups of differing duration's between the two groups.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr. Agustín Sampietro</name_or_title>
      <organization>Universidad de Buenos Aires</organization>
      <phone>+5491158336327</phone>
      <email>asampietro@live.com.ar</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

